According to Eagle Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are $35.65 M. In 2022 the company made an earning of $65.87 M an increase over its 2021 earnings that were of -$2.92 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $35.65 M | -45.87% |
2022 | $65.87 M | -2361.45% |
2021 | -$2.92 M | -111.53% |
2020 | $25.25 M | 2.31% |
2019 | $24.68 M | -32.89% |
2018 | $36.77 M | -50.35% |
2017 | $74.08 M | 38.63% |
2016 | $53.43 M | 1966.43% |
2015 | $2.58 M | -111.46% |
2014 | -$22.58 M | 282.82% |
2013 | -$5.9 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $21.36 B | 59,809.14% | ๐บ๐ธ USA |
![]() Novartis NVS | $9.82 B | 27,458.26% | ๐จ๐ญ Switzerland |
![]() Eli Lilly LLY | $7.56 B | 21,103.62% | ๐บ๐ธ USA |
![]() Amgen AMGN | $4.34 B | 12,084.86% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | -$5.85 B | -16,494.18% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $6.88 B | 19,208.23% | ๐ฌ๐ง UK |
![]() Teva Pharmaceutical Industries TEVA | $0.18 B | 421.61% | ๐ฎ๐ฑ Israel |